Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide

• Główni autorzy: Ashley Munchel (Autor), Chimen Kesserwan (Autor), Heather J. Symons (Autor), Leo Luznik (Autor), Yvette L. Kasamon (Autor), Richard J. Jones (Autor), Ephraim J. Fuchs (Autor)
• Format: Książka
• Wydane: MDPI AG, 2011-06-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Allogeneic stem cell transplantation (SCT) from an HLA-haploidentical relative provides a potentially curative treatment option for hematologic malignancies patients who lack a suitably HLA-matched donor. The greatest challenge to performing HLA-haploidentical SCT has been high rates of graft failur...